NASDAQ:RGLS - Regulus Therapeutics Earnings Date, Estimates & History

Get Started

$1.04 -0.07 (-6.31 %)

(As of 03/22/2019 04:00 PM ET)

Previous Close$1.04

Today's Range$1.01 - $1.10

52-Week Range$0.80 - $10.26

Volume136,278 shs

Average Volume367,926 shs

Market Capitalization$11.17 million

P/E Ratio-0.19

Dividend YieldN/A

Beta2.26

Regulus Therapeutics (NASDAQ:RGLS) Earnings History and Estimates Chart

Earnings by Quarter for Regulus Therapeutics (NASDAQ:RGLS)

Regulus Therapeutics (NASDAQ:RGLS) Earnings Estimates

2019 EPS Consensus Estimate: ($3.78)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2019	1	($1.18)	($1.18)	($1.18)
Q2 2019	1	($1.22)	($1.22)	($1.22)
Q3 2019	1	($0.07)	($0.07)	($0.07)
Q4 2019	1	($1.31)	($1.31)	($1.31)

Regulus Therapeutics (NASDAQ RGLS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/9/2019 (Estimated)
3/18/2019	12/31/2018	($0.92)	($0.98)	($0.98)	$7.01 million	$0.02 million	View	N/A
11/8/2018	Q3	($1.2520)	($1.18)	($1.18)	$0.02 million	$0.02 million	View	N/A
8/9/2018	Q2 2018	($0.1550)	($0.1330)	($0.13)	$0.02 million	$0.02 million	View	N/A
5/10/2018	Q1 2018	($0.15)	($0.15)	($0.15)	$0.02 million	$0.02 million	View	N/A
3/7/2018	Q4 2017	($0.17)	($0.14)	($0.14)	$0.02 million	$0.02 million	View	Listen
11/7/2017	Q3 2017	($0.18)	($0.18)	($0.18)	$0.02 million	$0.02 million	View	N/A
8/1/2017	Q2 2017	($0.31)	($0.4060)	($0.41)	$0.02 million	$0.02 million	View	Listen
5/4/2017	Q1 2017	($0.33)	($0.38)	($0.38)	$0.02 million	$0.02 million	View	N/A
3/2/2017	Q4 2016	($4.32)	($4.56)	($4.56)	$0.20 million	$0.02 million	View	Listen
11/1/2016	Q3 2016	($0.39)	($0.37)	($0.37)	$0.50 million	$0.20 million	View	N/A
8/2/2016	Q2 2016	($4.68)	($4.80)	($4.80)	$0.50 million	$0.48 million	View	Listen
5/2/2016	Q1 2016	($3.96)	($4.80)	($4.80)	$2.25 million	$0.49 million	View	Listen
2/22/2016	Q4 2015	($3.12)	($1.68)	($1.68)	$5.09 million	$10.90 million	View	Listen
11/5/2015	Q3 2015	($4.80)	($3.00)	($3.00)	$3.57 million	$1.87 million	View	N/A
8/4/2015	Q2 2015	($3.72)	($4.92)	($4.92)	$2.40 million	$3.80 million	View	N/A
5/7/2015	Q1 2015	($3.12)	($3.00)	($2.52)	$3.38 million	$4.20 million	View	Listen
2/18/2015	Q4 2014	($3.00)	($2.40)	$0.84	$2.24 million	$4.22 million	View	Listen
11/5/2014	Q3 2014	($2.52)	($3.60)	($4.08)	$2.76 million	$1.08 million	View	Listen
8/6/2014	Q2 2014	($2.64)	($3.72)	($3.96)	$3.20 million	$0.74 million	View	N/A
5/8/2014	Q1 2014	($1.92)	($3.00)	($2.40)	$3.80 million	$1.63 million	View	N/A
2/27/2014	Q4 2013	($1.68)	($1.80)	($2.28)	$3.69 million	$5.45 million	View	N/A
11/13/2013	Q3 2013	($0.16)	($0.07)	($0.07)	$3.56 million	$6.12 million	View	N/A
8/13/2013	Q2 2013	($1.80)	($1.44)	($0.48)	$3.44 million	$4.80 million	View	N/A
5/14/2013	Q1 2013	($0.09)	($0.20)	($0.20)	$2.96 million	$3.24 million	View	N/A
2/20/2013	Q412	($0.08)	($0.22)		$3.50 million	$3.24 million	View	N/A
11/19/2012	Q312		($15.98)		$3.81 million	$2.80 million	View	N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: Are FAANG stocks a good investment?